Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

3SBio, Inc. engages in the provision of biopharmaceutical business.It develops, research, manufactures and market biopharmaceutical products which are used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.The company was... 
More about the company
Surperformance© ratings of 3SBio Inc. (ADR)
Trading Rating : Investor Rating :
More Ratings
Latest news on 3SBIO INC. (ADR)
11/23 3SBIO : to add stake in biopharmaceutical firm
10/22 3SBIO : Signs Exclusive Patent License Agreement for ALT-P7, an Antibody-drug Co..
10/12 3SBIO : Inks Licensing Agreement with Alteogen
08/27 3SBIO : Selected as a Constituent of the Hang Seng Composite LargeCap & MidCap I..
08/17 3SBIO : Selected as a Constituent of the Hang Seng Composite LargeCap & MidCap I..
07/24 3SBIO : to buy pharmaceutical firm at Rmb528m
07/24 3SBIO : Acquires Zhejiang Wansheng Pharmaceutical
06/23 3SBIO : buys global rights to anti-TNF mAb technology
More news
Sector news : Bio Therapeutic Drugs
04:06p JUNO THERAPEUTICS : Announces Data Presentations at the American Society of Hema..
07:02a INCYTE : Jakafi® (ruxolitinib) to be Featured in over 60 Abstracts at ASH Annual..
11/27 SANOFI : And regeneron announce 18,000-patient odyssey outcomes trial of praluen..
More sector news : Bio Therapeutic Drugs